Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studies

Purpose: Immune checkpoint and antiangiogenic inhibitors have a potentially synergistic antitumor effect. We aimed to assess the efficacy and safety of immunotherapy in combination with antiangiogenesis therapy with or without chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ruo-Lin, Song, Jun, Sun, Li, Wu, Zhi-Xuan, Yi, Xiao-Fang, Zhang, Shu-Ling, Huang, Le-Tian, Ma, Jie-Tao, Han, Cheng-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399640/
https://www.ncbi.nlm.nih.gov/pubmed/36034821
http://dx.doi.org/10.3389/fphar.2022.920165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399640/
https://www.ncbi.nlm.nih.gov/pubmed/36034821
http://dx.doi.org/10.3389/fphar.2022.920165

Ejemplares similares